ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

Poordad F, Hézode C, Trinh R, et al. ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis. Kowdley KV, Zeuzem S, Agarwal K, Shiffman ML, Wedemeyer H, Berg T, et al. N Engl J Med. 2014;370(21):1973-1982.

Publication Type:

Journal Article

Authors:

Fred Poordad; Christophe Hézode; Trinh, R.; et, al

Source:

N Engl J Med, Volume 370, Issue 21, p.1973-1982 (2014)

Keywords:

Adult, Antiviral Agents, Body Weight, British Columbia, Canada, Chicago, CLASS, Disease, Fatigue, France, Genotype, genotype 1, Germany, HCV, Headache, Health, hepatitis, Hepatitis C, hepatitis C virus, Infection, Liver, London, methods, Nausea, NS5A inhibitor, Paris, Patients, protease inhibitor, Ribavirin, ritonavir, sustained virologic response, Texas, therapy, treatment

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/24725237

Export Citation:
RIS Format
Top